Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 25, 2024 01:30 ET | Source: ONWARD Medical NV

ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date

ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date
April 11, 2024 01:30 ET | Source: ONWARD Medical NV

ONWARD® Medical Announces Publication of Full Year 2023 Financial Results and Business Update Webcast

ONWARD® Medical Announces Publication of Full Year 2023 Financial Results and Business Update Webcast
April 09, 2024 01:00 ET | Source: ONWARD Medical NV

Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00

Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00
April 02, 2024 01:30 ET | Source: ONWARD Medical NV

ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System

ONWARD Medical has submitted its De Novo application to the US Food and Drug Administration (FDA) to allow marketing of its breakthrough ARC-EX System.
March 25, 2024 12:40 ET | Source: ONWARD Medical NV

ONWARD® Medical Publishes Closing of Accelerated Bookbuild Offering and Public Offering in France

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL....
March 21, 2024 13:26 ET | Source: ONWARD Medical NV

ONWARD® Medical Publishes Prospectus for Listing of New Shares

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL....
March 20, 2024 22:03 ET | Source: ONWARD Medical NV

ONWARD® Medical Lève avec Succès 20 millions d'euros dans le cadre d'une Augmentation de Capital par le biais d'une Procédure de Construction Accélérée d'un Livre d'Ordres et d'une Offre au Public en France

NE PAS DISTRIBUER OU DIFFUSER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS, AU CANADA, EN AUSTRALIE OU AU JAPON OU DANS TOUTE AUTRE JURIDICTION DANS LAQUELLE LA DISTRIBUTION OU LA DIFFUSION SERAIT...
March 20, 2024 22:03 ET | Source: ONWARD Medical NV

ONWARD® Medical Successfully Raises €20 Million in a Capital Increase by Way of an Accelerated Bookbuild Offering and by Way of a Public Offering in France

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL....
March 20, 2024 13:29 ET | Source: ONWARD Medical NV

ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Public Offering in France for an Indicative Amount of EUR 15 Million, with an Up to EUR 5 Million Upsize Option

EINDHOVEN, the Netherlands, March 20, 2024 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER...
March 20, 2024 13:24 ET | Source: ONWARD Medical NV

ONWARD® Medical Lance une Augmentation de Capital par le Biais d'une Procédure de Construction Accélérée d'un Livre d'Ordres et le Biais d'une Offre au Public en France d'un Montant Indicatif de 15 millions d'euros avec l’Option de Lever j

EINDHOVEN, the Netherlands, 20 mars 2024 (GLOBE NEWSWIRE) -- NE PAS DISTRIBUER OU DIFFUSER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS, AU CANADA, EN AUSTRALIE OU AU JAPON OU DANS TOUTE AUTRE...